Cell Analysis, Inc.
Country not established
- Devices
- 1
What Cell Analysis, Inc. makes
Cell Analysis, Inc. manufactures the QCA (Version 3.1), a quantitative coronary angiography analysis system designed for assessing coronary artery stenosis and vessel geometry from angiographic images.
The QCA system is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Qca (Version 3.1) Ref K031363
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Cell Analysis, Inc. have in the registry?
The registry currently lists 1 device for Cell Analysis, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Cell Analysis, Inc.'s devices?
Among its 1 most recently registered device, Cell Analysis, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Cell Analysis, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Cell Analysis, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Cell Analysis, Inc. in the registry?
The most recently registered devices listed for Cell Analysis, Inc. include QCA (VERSION 3.1).